EUVIMEDEUVIMED entdecken
VergleichsstudieMultizentrische StudieBeobachtungsstudieKohortenstudieOpen Access

Nonsteroidal Versus Steroidal Mineralocorticoid Receptor Antagonists in Heart Failure: Real‐World Evidence From a Multicenter Cohort Study

Jheng-Yan Wu iD, Kuan-Jui Tseng, Yu-Min Lin iD

Journal of the American Heart Association · 04.11.2025 · 14 (21)

DOI: 10.1161/jaha.125.043373 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of the American Heart Association, erschienen am 04.11.2025. Verfasst von Jheng-Yan Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition Chi Mei Medical Centre Tainan Taiwan. Hauptthemen laut MEDLINE: Heart Failure, Mineralocorticoid Receptor Antagonists, Naphthyridines. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mineralocorticoid receptor antagonists (MRAs) reduce mortality and hospitalization in patients with heart failure (HF). Finerenone, a selective nonsteroidal MRA, has recently demonstrated clinical benefits in patients with HF. However, real‐world evidence comparing nonsteroidal and steroidal MRAs in HF is lacking.

Methods

We conducted a retrospective, propensity score–matched cohort study using the TriNetX database. Adult patients diagnosed with HF from January 2021 to February 2025 who initiated nonsteroidal or a steroidal MRA were included. The primary outcome was a composite of all‐cause mortality, all‐cause hospitalization, and worsening HF at 1 year. Secondary outcomes included each component individually and safety events. Subgroup and sensitivity analyses were performed, including Kaplan–Meier survival, E‐value estimation, and landmark analysis.

Results

After matching, 1619 patients were included in each group. The incidence of the primary composite outcome was significantly lower in the nonsteroidal MRAs group (hazard ratio [HR], 0.79 [95% CI, 0.70–0.90]; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureMineralocorticoid Receptor AntagonistsNaphthyridinesAgedFemaleHumansMaleMiddle AgedHospitalizationPropensity ScoreRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

HFfinerenonenonsteroidal MRAssteroidal MRAs

Substanzen

finerenoneMineralocorticoid Receptor AntagonistsNaphthyridines

Autor:innen und Institutionen

  • Department of Nutrition Chi Mei Medical Centre Tainan Taiwan.
  • Department of Public Health College of Medicine, National Cheng Kung University Tainan Taiwan.
  • Division of Cardiology, Department of Internal Medicine Chi Mei Medical Centre Tainan Taiwan.
  • Division of Cardiology, Department of Internal Medicine Chi Mei Medical Centre, Chiali Tainan Taiwan.

ORCID-Profile: Jheng-Yan Wu, Yu-Min Lin

Zitieren

APA

Wu, J. Y., Tseng, K. J., & Lin, Y. M. (2025). Nonsteroidal Versus Steroidal Mineralocorticoid Receptor Antagonists in Heart Failure: Real‐World Evidence From a Multicenter Cohort Study. Journal of the American Heart Association, 14(21). https://doi.org/10.1161/jaha.125.043373

Vancouver

Wu JY, Tseng KJ, Lin YM. Nonsteroidal Versus Steroidal Mineralocorticoid Receptor Antagonists in Heart Failure: Real‐World Evidence From a Multicenter Cohort Study. Journal of the American Heart Association. 2025;14(21). doi:10.1161/jaha.125.043373

BibTeX
@article{Wu2025,
  author = {Wu, Jheng-Yan and Tseng, Kuan-Jui and Lin, Yu-Min},
  title = {Nonsteroidal Versus Steroidal Mineralocorticoid Receptor Antagonists in Heart Failure: Real‐World Evidence From a Multicenter Cohort Study},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {21},
  doi = {10.1161/jaha.125.043373}
}
Kostenlos starten →